
Jack R. Andrews, MD, discusses BED-PSMA-411 findings comparing PSMA-PET detection rates and urinary excretion in prostate cancer biochemical recurrence.
In this video, J. Curtis Nickel, MD, FRCSC, discusses the first two parts of the study, “Serenoa repens (saw palmetto) for lower urinary tract symptoms (LUTS): The evidence for efficacy and safety of lipidosterolic extracts,” which was conducted by Stephen B. Strum, MD, FACP. Nickel is a professor of urology at Queen’s University, and a research chair in urologic pain and inflammation at Kingston Health Sciences Centre, Kingston, Ontario, Canada.






